CA1085832A - Prostaglandin analogs - Google Patents

Prostaglandin analogs

Info

Publication number
CA1085832A
CA1085832A CA261,914A CA261914A CA1085832A CA 1085832 A CA1085832 A CA 1085832A CA 261914 A CA261914 A CA 261914A CA 1085832 A CA1085832 A CA 1085832A
Authority
CA
Canada
Prior art keywords
phenyl
carbon atoms
process according
hydroxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA261,914A
Other languages
English (en)
French (fr)
Inventor
Thomas K. Schaaf
Jasjit S. Bindra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Application granted granted Critical
Publication of CA1085832A publication Critical patent/CA1085832A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CA261,914A 1975-09-29 1976-09-23 Prostaglandin analogs Expired CA1085832A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/617,481 US4065472A (en) 1975-09-29 1975-09-29 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
US617,481 1975-09-29

Publications (1)

Publication Number Publication Date
CA1085832A true CA1085832A (en) 1980-09-16

Family

ID=24473823

Family Applications (1)

Application Number Title Priority Date Filing Date
CA261,914A Expired CA1085832A (en) 1975-09-29 1976-09-23 Prostaglandin analogs

Country Status (11)

Country Link
US (1) US4065472A (enExample)
JP (1) JPS5242872A (enExample)
BE (1) BE846650A (enExample)
CA (1) CA1085832A (enExample)
DE (1) DE2640692C3 (enExample)
DK (1) DK435276A (enExample)
FR (1) FR2325371A1 (enExample)
GB (1) GB1508925A (enExample)
IE (1) IE44067B1 (enExample)
LU (1) LU75904A1 (enExample)
NL (1) NL7610761A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
CA2705150C (en) * 2007-11-09 2016-06-14 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350971A (en) 1971-05-11 1974-04-24 Imp Chemi Als Ind Ltd Cyclopentane derivatives
US3922289A (en) * 1973-02-23 1975-11-25 Syntex Inc Trans-prostaglandin-like compounds and methods

Also Published As

Publication number Publication date
FR2325371A1 (fr) 1977-04-22
IE44067L (en) 1977-03-29
DK435276A (da) 1977-03-30
BE846650A (fr) 1977-03-28
US4065472A (en) 1977-12-27
LU75904A1 (enExample) 1977-05-11
IE44067B1 (en) 1981-08-12
DE2640692C3 (de) 1979-09-13
GB1508925A (en) 1978-04-26
JPS5242872A (en) 1977-04-04
JPS5437136B2 (enExample) 1979-11-13
DE2640692B2 (enExample) 1979-01-18
DE2640692A1 (de) 1977-03-31
NL7610761A (nl) 1977-03-31
FR2325371B1 (enExample) 1978-12-22

Similar Documents

Publication Publication Date Title
US3932389A (en) 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US4024179A (en) Substituted ω-pentanorprostaglandins
US4304907A (en) Bicyclo lactone intermediates for prostaglandin analogs
US4029681A (en) 13,14-Didehydro-PG analogs
US3962293A (en) 13,14-Dihydro-16-fluoro prostaglandin F1
US3883513A (en) Tetrazoyl derivatives of naturally occurring prostaglandins
US3933889A (en) 4,5-Cis-didehydro-PGF1.sub.α analogs
CA1085831A (en) Preparation of substituted w-pentanorprostaglandins
US4013695A (en) 4,4,5,5-Tetradehydro-PGE1 analogs
US4169895A (en) Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4157341A (en) 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
CA1092103A (en) 11-deoxy acetylenic aryl prostaglandins
US4060534A (en) 9-Deoxy-9-methylene-PGF compounds
US4126754A (en) 11-Deoxy-cis-4,5-didehydro-ω-aryl-PGE compounds
US3984424A (en) P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
US4154949A (en) 11-Desoxy-15-substituted-ω-pentanor prostaglandins
US4229585A (en) Fluoro-prostaglandins
CA1047491A (en) Prostaglandin-type compounds and process for their preparation
US3969381A (en) 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969376A (en) 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
IE43815B1 (en) 11-desoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins
US4018803A (en) 13,14-Didehydro-PG3 compounds
US3969379A (en) 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US4130721A (en) 11-Deoxy PGE2 compounds
US4065472A (en) 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins

Legal Events

Date Code Title Description
MKEX Expiry